By Buy This GLP Editorial Team · Editorial profile: Carla Medina
Navio MD review
Dose-dependent starting prices
Navio advertises starting figures for branded and compounded tirzepatide. The actual price depends on the product and plan.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
Navio MD advertises compounded tirzepatide from $189 per month and branded Zepbound from $445. Its product pages say the final charge depends on product and plan, so those figures cannot establish a monthly renewal price.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Pricing transparency
How Navio MD publishes its prices
To compare six months of treatment costs, ask Navio for the prescription price at each dose and the upfront charge for the selected plan. The Primary Clinic review shows how published dose bands and a separate care fee make that comparison easier. The public starting figures are $189 and $445, with no complete dose or renewal schedule shown.
At a glance
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- States
- 48
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What Navio MD is
Navio MD’s current public weight-loss catalog lists compounded tirzepatide and branded Zepbound pens.
How it works
Navio says its Basic option includes the provider visit, treatment plan and medication if prescribed, without a membership. Its optional Support plan is $75 per month and prices medication separately.
Branded or compounded
Zepbound is an FDA-approved tirzepatide product. The separately listed compounded preparation does not go through FDA approval.
Where the money holds, and where it moves
Predictable
- Shows separate starting figures for branded and compounded products
- Explains what Basic and optional Support include
Moves, or is not stated
- Starting figures do not establish renewal costs
- The public pages do not show a complete dose price schedule
Who this is worth it for
People comparing the two listed treatment options who can request a complete quote.
Who should price elsewhere
People who need a fixed refill rate before consultation.
The molecules
What Navio MD prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside Navio MD
Kin MedsPeople comparing clinician access and who can confirm medication charges before ordering.
See Kin Meds →
MaximusPeople who can compare the full initial and renewal prices for the offer available to them.
See Maximus →
FoundReaders comparing a longer commitment with paying cycle to cycle
See Found →
More GLP-1 telehealth sellers priced end to end: SurpassMDSynergenX HealthSynergy RxT2D.comTD Tele-Doc Weight LossTeleCareSpot
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Does the $75 Support plan cover medication?
Is the $189 figure the ongoing charge?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare Navio MD against every seller on it.